ArticleHealthcare (Basel, Switzerland)2025

The Cost of Downstream Adverse Outcomes Associated with Allogeneic Blood Transfusion: A Retrospective Observational Cohort Study.

Michelle Roets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.